School of Graduate Studies

School of Graduate Studies
School of Graduate Studies

Graduate Diploma in Pharmaceutical & Healthcare Management and Innovation (G.Dip PHMI)

Program Contacts

Program Director
Dr. Chandra Tayade
Department of Biomedical and Molecular Sciences
Phone: 613-533-6354
E-mail: tayadec@queensu.ca

Program Assistants (for application queries)
Emily Greenwood (emily.greenwood@Queensu.ca)

 

Program Overview

The proposed Graduate Diploma in Pharmaceutical & Healthcare Management and Innovation is targeted to enhance the competitiveness and employability of graduate students interested in pursuing careers in pharmaceutical and related health industries. Graduates of this program will possess the requisite knowledge, skills, and experience to make them ideal candidates to enter progressive career positions. The diploma will offer a combination of course work and practical experience to recent graduates in the health and science sectors (e.g. MD, MSc, PhD, PharmD) from across Canada and internationally.

Opportunities

This program is developed to specifically enhance relevant industry or institutional experience, practical knowledge of the process of commercializing medical innovation, and business acumen that would strengthen the competitiveness of new applicants for early-stage industrial/academic career opportunities. In the course work component, students will participate in seminars led by pharmaceutical and related health industry experts, engage in case studies of real-world problems and challenges, and prepare oral and written submissions that demonstrate effective teamwork and problem-solving skills. The internship with industry will provide an opportunity for the student to be immersed on a full-time basis with an employer in the private or government sectors, to acquire valuable hands-on experience and apply the knowledge and skills acquired during coursework.

Career Paths - Employment opportunities

Graduates of this diploma will have the knowledge and skills required to pursue advanced career prospects in the broader health sector, including but not limited to, opportunities with: Federal health departments and agencies (e.g. Health Canada, the Canadian Agency for Drugs and Technologies in Health); Provincial health ministries; Corporations (e.g. private insurance/pharmacy benefit management companies, pharmaceutical/medical device companies, contract research organizations or health service corporations that provide biopharmaceutical and commercial outsourcing services); Entrepreneurial ventures (e.g. start-up companies).

Degrees Offered
  • Graduate Diploma in Pharmaceutical & Healthcare Management and Innovation
Method of Completion

The program will be 10 months in duration. Students will complete two online courses over one academic term, followed by a six month, full-time paid internship position with an external partner. It is anticipated that internship start dates will be in January.

Successful completion of the online courses is a requirement for progression into the internship.

Term 1 (4 months) complete:

  • Online – PHMI 871 (3.0 units) – Healthcare Innovation and Development
  • Online – PHMI 872 (3.0 units) – Healthcare Management and Commercialization

Term 2 (6 months) complete:

  • Internship – PHMI 873 (6.0 units) – Internship in Healthcare Management & Innovation 
Faculty

Guest Lecturers

  • Babak Abbaszadeh, Vice President Medical Affairs, BMS
  • Mike Wells, Assistant Director Commercial Development, Technology Transfer Unit (TTU) Office of Partnerships and Innovation (OPI) Queen’s University
  • Mark McGovern, Medical Science Liaison, Merck Canada
  • Elaine Vandenberg, Vandenberg Quality Consulting
  • Rocelyn DelCarmen, Director Regulatory Affairs and Quality Assurance, AstraZeneca
  • Lorenzo Biondi, Consultant, Past Vice President Medical and Regulatory Affairs, Roche
  • Paul Brennan, Vice President Business Development, Aquinox Pharmaceuticals
  • Vita Peri, BioStrat Consulting
  • Sevag Sahakian, Director Medical Affairs, Merck
  • Laura Knuckle, General Counsel, EMD Serono
  • Erin Murphy, Head Operational Excellence, EMD Serono
  • Mike Duong, Director, Evidence Generation - Medical Affairs, Roche
  • Ed Dybka, President, QIV Capital, Past President, AstraZeneca Canada
Academic Prerequisites, Deadlines, Fees & Funding

Academic Prerequisites

  1. A MD, PharmD, MSc, or PhD in biomedical, pharmaceutical or public health sciences from a recognized University

  2. A minimum of an A- standing in the highest obtained Degree is required for program entry

  3. Applicants will also be required to submit a Personal Statement that outlines how the learning objectives of the program align with their career aspirations; and

  4. A Curriculum Vitae that includes information on relevant extracurricular or work experience; and two academic references from individuals familiar with the candidate’s academic performance which will be considered by admissions personnel

  5. International applicants would only be eligible to apply if the internship position can be secured without the requirement for a work permit in the country where the internship position would be taking place.

Test Requirements

English Language Proficiency: English is the language of instruction at Queen’s University and candidates must be able to communicate competently in English, both orally and in writing. Therefore, applicants whose native languages do not include English will be required to obtain satisfactory standing in an English Language Proficiency Test as part of the application process, and before final acceptance is granted as per School of Graduate Studies regulations.

Key Dates & Deadline

Application Deadline:

July 1st, 2019 for a September 1st, 2019 start. If you are eligible and interested in our programs, please submit your online application via the School of Graduate Studies

NB: International applicants would only be eligible to apply if the internship position can be secured without the requirement for a work permit in the country where the internship position would be taking place.

Fees

  • Application Fee: $105
  • Program Tuition Fee:
    • Domestic - $15,000 CAD ($7,500 per term)
    • International - $25,000 CAD ($12,500 per term)
Learning Outcomes
  1. Acquire and apply knowledge of historical approaches to, and contributions of, medical innovation to identify potential future directions of medical innovation and processes for commercialization.

  2. Develop a broad understanding of the regulatory and compliance landscape in Canada and beyond to support approval of new therapeutics.

  3. Gain exposure to leading roles in private or institutional healthcare organizations to build an understanding of the many scientific, medical, and commercial functions of these organizations, their responsibilities, and how they interface to develop and commercialize healthcare innovations.

  4. Identify and utilize required professional skills to successfully interact with key stakeholders, colleagues, and customers in the healthcare ecosystem.